102 related articles for article (PubMed ID: 16439062)
1. Remnant epitopes, autoimmunity and glycosylation.
Opdenakker G; Dillen C; Fiten P; Martens E; Van Aelst I; Van den Steen PE; Nelissen I; Starckx S; Descamps FJ; Hu J; Piccard H; Van Damme J; Wormald MR; Rudd PM; Dwek RA
Biochim Biophys Acta; 2006 Apr; 1760(4):610-5. PubMed ID: 16439062
[TBL] [Abstract][Full Text] [Related]
2. Remnant epitopes generate autoimmunity: from rheumatoid arthritis and multiple sclerosis to diabetes.
Descamps FJ; Van den Steen PE; Nelissen I; Van Damme J; Opdenakker G
Adv Exp Med Biol; 2003; 535():69-77. PubMed ID: 14714889
[TBL] [Abstract][Full Text] [Related]
3. Chemokines and proteinases in autoimmune diseases and cancer.
Opdenakker G; Van Damme J
Verh K Acad Geneeskd Belg; 2002; 64(2):105-36. PubMed ID: 12085566
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis.
Van den Steen PE; Proost P; Grillet B; Brand DD; Kang AH; Van Damme J; Opdenakker G
FASEB J; 2002 Mar; 16(3):379-89. PubMed ID: 11874987
[TBL] [Abstract][Full Text] [Related]
5. Generation of glycosylated remnant epitopes from human collagen type II by gelatinase B.
Van den Steen PE; Proost P; Brand DD; Kang AH; Van Damme J; Opdenakker G
Biochemistry; 2004 Aug; 43(33):10809-16. PubMed ID: 15311942
[TBL] [Abstract][Full Text] [Related]
6. On the roles of extracellular matrix remodeling by gelatinase B.
Opdenakker G
Verh K Acad Geneeskd Belg; 1997; 59(6):489-514. PubMed ID: 9543820
[TBL] [Abstract][Full Text] [Related]
7. Gelatinase B functions as regulator and effector in leukocyte biology.
Opdenakker G; Van den Steen PE; Dubois B; Nelissen I; Van Coillie E; Masure S; Proost P; Van Damme J
J Leukoc Biol; 2001 Jun; 69(6):851-9. PubMed ID: 11404367
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease.
Cauwe B; Martens E; Sagaert X; Dillen C; Geurts N; Li S; Mertens J; Thijs G; Van den Steen PE; Heremans H; De Vos R; Blockmans D; Arnold B; Opdenakker G
J Autoimmun; 2011 May; 36(3-4):239-52. PubMed ID: 21376533
[TBL] [Abstract][Full Text] [Related]
9. Gelatinase B in multiple sclerosis and experimental autoimmune encephalomyelitis.
Dubois B; Opdenakker G; Carton H
Acta Neurol Belg; 1999 Mar; 99(1):53-6. PubMed ID: 10218093
[TBL] [Abstract][Full Text] [Related]
10. Gelatinase B/Matrix Metalloproteinase-9 as Innate Immune Effector Molecule in Achalasia.
Furuzawa-Carballeda J; Boon L; Torres-Villalobos G; Romero-Hernández F; Ugarte-Berzal E; Martens E; Vandooren J; Rybakin V; Coss-Adame E; Valdovinos M; Velazquez-Fernández D; Opdenakker G
Clin Transl Gastroenterol; 2018 Nov; 9(11):208. PubMed ID: 30449890
[TBL] [Abstract][Full Text] [Related]
11. Gelatinase B: a tuner and amplifier of immune functions.
Opdenakker G; Van den Steen PE; Van Damme J
Trends Immunol; 2001 Oct; 22(10):571-9. PubMed ID: 11574282
[TBL] [Abstract][Full Text] [Related]
12. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
Vandooren J; Van den Steen PE; Opdenakker G
Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
[TBL] [Abstract][Full Text] [Related]
13. Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases.
Opdenakker G; Proost P; Van Damme J
Trends Mol Med; 2016 Sep; 22(9):746-757. PubMed ID: 27491925
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
15. Gelatinase B participates in collagen II degradation and releases glycosylated remnant epitopes in rheumatoid arthritis.
Van den Steen PE; Grillet B; Opdenakker G
Adv Exp Med Biol; 2005; 564():45-55. PubMed ID: 16400806
[No Abstract] [Full Text] [Related]
16. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with cathepsin K.
Sassi ML; Eriksen H; Risteli L; Niemi S; Mansell J; Gowen M; Risteli J
Bone; 2000 Apr; 26(4):367-73. PubMed ID: 10719280
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase B and chemokines in leukocytosis and stem cell mobilization.
Starckx S; Van den Steen PE; Wuyts A; Van Damme J; Opdenakker G
Leuk Lymphoma; 2002 Feb; 43(2):233-41. PubMed ID: 11999552
[TBL] [Abstract][Full Text] [Related]
18. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.
Okada Y; Naka K; Kawamura K; Matsumoto T; Nakanishi I; Fujimoto N; Sato H; Seiki M
Lab Invest; 1995 Mar; 72(3):311-22. PubMed ID: 7898050
[TBL] [Abstract][Full Text] [Related]
19. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats aged 0-21 days: II. Two proteinases, gelatinase B and collagenase-3, are implicated in the lysis of collagen fibrils.
Davoli MA; Lamplugh L; Beauchemin A; Chan K; Mordier S; Mort JS; Murphy G; Docherty AJ; Leblond CP; Lee ER
Dev Dyn; 2001 Sep; 222(1):71-88. PubMed ID: 11507770
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated glycoforms of gelatinase B exhibit a decreased level of binding to galectin-3.
Fry SA; Van den Steen PE; Royle L; Wormald MR; Leathem AJ; Opdenakker G; McDonnell JM; Dwek RA; Rudd PM
Biochemistry; 2006 Dec; 45(51):15249-58. PubMed ID: 17176047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
